Skip to content

Dr. Reddy's Laboratories

US · RDY #1451 by market cap Listed 1970
14.89 +0.06 +0.40%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

About Dr. Reddy's Laboratories

Dr. Reddy's Laboratories Ltd. engages in the manufacture and marketing of pharmaceutical products. It operates through the following segments: Global Generics, Pharmaceutical Services and Active Ingredients, and Others. The Global Generics segment refers to the manufacturing and marketing of prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name or as generic finished dosages with therapeutic equivalence to branded formulations. The Pharmaceutical Services and Active Ingredients segment focuses on manufacturing and marketing of active pharmaceutical ingredients and intermediates, also known as API, which are the principal ingredients for finished pharmaceutical products. The Others segment includes the operations of the subsidiary of the company. The company was founded by Kallam Anji Reddy on February 24, 1984 and is headquartered in Hyderabad, India.

Founded
1984
CEO
Mr. Erez Israeli
Employees
27,527
Headquarters
Hyderabad, Telangana, India
Fiscal year end
03-31
Website
drreddys.com

Company profile

Exchange
US
Symbol
RDY
Market-cap rank
#1451
Listing date
1970-01-01
Market cap
12.41B
Float cap
8.94B
Shares out
833.66M
Float shares
600.65M

Sectors & themes

Browse all sectors & themes

Quote time 2026-11-20 20:02:31 · For reference only, not investment advice and not tailored to your situation.

Dr. Reddy's Laboratories discussion 0 comments

Add a comment